Rosa Jimenez-Lucena
Instituto de Salud Carlos III
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rosa Jimenez-Lucena.
Molecular Nutrition & Food Research | 2017
Javier Lopez-Moreno; Gracia M. Quintana-Navarro; Antonio Camargo; Rosa Jimenez-Lucena; Javier Delgado-Lista; Carmen Marin; Francisco J. Tinahones; Gary E. Striker; Helen M. Roche; Pablo Perez-Martinez; Jose Lopez-Miranda; Elena M. Yubero-Serrano
SCOPE Advanced glycation end products (AGEs) increase in dysmetabolic conditions. Lifestyle, including diet, has shown be effective in preventing the development of metabolic syndrome (MetS). We investigated whether AGE metabolism is affected by diets with different fat quantity and quality in MetS patients. METHODS AND RESULTS A randomized, controlled trial assigned 75 MetS patients to one of four diets: high SFA (HSFA), high MUFA (HMUFA), and two low-fat, high-complex carbohydrate diets (LFHCC) supplemented with long-chain n-3 PUFA or placebo for 12-weeks each. Dietary and serum AGE [methylglyoxal (MG: lysine-MG-H1) and N-carboxymethyllysine] levels and gene expression related to AGE metabolism in peripheral blood mononuclear cells (AGER1, RAGE, GloxI, and Sirt1 mRNA) were determined. HMUFA diet reduced serum AGE (sAGE) and RAGE mRNA, increased AGER1 and GloxI mRNA levels compared to the other diets. LFHCC n-3 diet reduced sAGE levels and increased AGER1 mRNA levels compared to LFHCC and HSFA diets. Multiple regression analyses showed that sMG and AGER1 mRNA appeared as significant predictors of oxidative stress/inflammation-related parameters. CONCLUSIONS Low AGE content in HMUFA diet reduces sAGEs and modulates the gene expression related to AGE metabolism in MetS patients, which may be used as a therapeutic approach to reduce the incidence of MetS and related chronic diseases.
Journal of Agricultural and Food Chemistry | 2017
Javier Lopez-Moreno; Sonia Garcia-Carpintero; Rosa Jimenez-Lucena; Carmen Haro; Oriol A. Rangel-Zuñiga; Ruth Blanco-Rojo; Elena M. Yubero-Serrano; Francisco J. Tinahones; Javier Delgado-Lista; Pablo Perez-Martinez; Helen M. Roche; Jose Lopez-Miranda; Antonio Camargo
Metabolic syndrome (MetS) results in postprandial metabolic alterations that predisposes one to a state of chronic low-grade inflammation and increased oxidative stress. We aimed to assess the effect of the consumption of the quantity and quality of dietary fat on fasting and postprandial plasma lipopolysaccharides (LPS). A subgroup of 75 subjects with metabolic syndrome was randomized to receive 1 of 4 diets: HSFA, rich in saturated fat; HMUFA, rich in monounsaturated fat; LFHCC n-3, low-fat, rich in complex carbohydrate diet supplemented with n-3 polyunsaturated fatty acids; LFHCC low-fat, rich in complex carbohydrate diet supplemented with placebo, for 12 weeks each. We administered a fat challenge reflecting the fatty acid composition of the diets at postintervention. We determined the plasma lipoproteins and glucose and gene expression in peripheral blood mononuclear cells (PBMC) and adipose tissue. LPS and LPS binding protein (LBP) plasma levels were determined by ELISA, at fasting and postprandial (4 h after a fat challenge) states. We observed a postprandial increase in LPS levels after the intake of the HSFA meal, whereas we did not find any postprandial changes after the intake of the other three diets. Moreover, we found a positive relationship between the LPS plasma levels and the gene expression of IkBa and MIF1 in PBMC. No statistically significant differences in the LBP plasma levels at fasting or postprandial states were observed. Our results suggest that the consumption of HSFA diet increases the intestinal absorption of LPS which, in turn, increases postprandial endotoxemia levels and the postprandial inflammatory response.
Experimental Gerontology | 2016
Oriol A. Rangel-Zuñiga; Andreea Corina; Beatriz Lucena-Porras; Cristina Cruz-Teno; Francisco Gomez-Delgado; Rosa Jimenez-Lucena; Juan F. Alcala-Diaz; Carmen Haro-Mariscal; Elena M. Yubero-Serrano; Javier Delgado-Lista; Javier Lopez-Moreno; Fernando Rodriguez-Cantalejo; Antonio Camargo; Francisco J. Tinahones; Jose M. Ordovas; Jose Lopez-Miranda; Pablo Perez-Martinez
BACKGROUND Several single nucleotide polymorphisms have been proposed as potential predictors of the development of age-related diseases. OBJECTIVE To explore whether Tumor Necrosis Factor Alpha (TNFA) gene variants were associated with inflammatory status, thus facilitating the rate of telomere shortening and its relation to cellular aging in a population with established cardiovascular disease from the CORDIOPREV study (NCT00924937). MATERIALS AND METHODS SNPs (rs1800629 and rs1799964) located at the TNFA gene were genotyped by OpenArray platform in 840 subjects with established cardiovascular disease. Relative telomere length was determined by real time PCR and plasma levels of C-reactive protein by ELISA. In a subgroup of 90 subjects, the gene expression profiles of TNFA, IKKβ, p47phox, p40phox, p22phox and gp91phox were determined by qRT-PCR. RESULTS GG subjects for the SNP rs1800629 at the TNFA gene showed shorter relative telomere length and higher plasma levels of hs-CRP than A-allele subjects (p<0.05). Consistent with these findings, the expression of pro-inflammatory (TNFA) and pro-oxidant (p47phox and the gp91phox) genes was higher in GG subjects than A allele subjects (p<0.05). CONCLUSION Subjects carrying the GG genotype for the SNP rs1800629 at the TNFA gene show a greater activation of the proinflammatory status than A-allele carriers, which is related to ROS formation. These ROS could induce DNA damage especially in the telomeric sequence, by decreasing the telomere length and inducing cellular aging. This effect may also increase the risk of the development of age-related diseases.
Maturitas | 2018
Jose A. Santos-Marcos; Oriol A. Rangel-Zuñiga; Rosa Jimenez-Lucena; Gracia M. Quintana-Navarro; Sonia Garcia-Carpintero; María M. Malagón; Blanca B. Landa; Manuel Tena-Sempere; Pablo Perez-Martinez; Jose Lopez-Miranda; Francisco Perez-Jimenez; Antonio Camargo
OBJECTIVES We explore the differences in the gut microbiota associated with gender and hormonal status. STUDY DESIGN We included 76 individuals in this study: 17 pre-menopausal women, 19 men matched by age, as a control group for the pre-menopausal women, 20 post-menopausal women and 20 men matched by age as a control group for the post-menopausal women; all 4 groups were also matched by body mass index (BMI) and nutritional background. MAIN MEASUREMENTS We analyzed the differences in the gut microbiota, endotoxemia, intestinal incretins, pro-inflammatory cytokines, and plasma levels of energy homeostasis regulatory hormones between pre- and post-menopausal women and compared them with their respective male control groups. RESULTS We found a higher Firmicutes/Bacteroidetes ratio, a higher relative abundance of Lachnospira and Roseburia, and higher GLP-1 plasma levels in pre-menopausal women than in post-menopausal women, who had similar levels to men. In contrast, we observed a lower relative abundance of the Prevotella, Parabacteroides and Bilophila genera, and IL-6 and MCP-1 plasma levels in pre-menopausal women than in post-menopausal women, who had similar levels to the men. We also found higher GiP and leptin plasma levels in women than in men, irrespective of the menopausal status of the women. In addition, adiponectin levels were higher in pre-menopausal women than in their corresponding age-matched male control group. CONCLUSIONS Our results suggest that the differences in the composition of gut microbiota between genders and between women of different hormonal status may be related to the sexual dimorphism observed in the incidence of metabolic diseases and their co-morbidities.
Journals of Gerontology Series A-biological Sciences and Medical Sciences | 2018
Andreea Corina; Oriol A. Rangel-Zuñiga; Rosa Jimenez-Lucena; Juan F. Alcala-Diaz; Gracia M. Quintana-Navarro; Elena M. Yubero-Serrano; Javier Lopez-Moreno; Javier Delgado-Lista; Francisco J. Tinahones; Jose M. Ordovas; Jose Lopez-Miranda; Pablo Perez-Martinez
Leukocyte telomere length (LTL) shortening is a biomarker of cellular aging that can be decelerated by diet. We aimed to investigate the effect of dietary intake of vitamin E on biomarkers of cellular senescence in patients with established cardiovascular disease. To this end, DNA from 1,002 participants of the CORDIOPREV study (NCT00924937) was isolated and LTL was measured by real-time PCR. Dietary information was collected using a 146-item food frequency questionnaire, and several oxidative stress and damage biomarkers were determined. We found that patients with an inadequate intake of vitamin E according to the European Food Safety Authority, U.S. Food and Nutrition Board, and Spanish dietary recommendation had shorter LTL than those with an adequate intake (p = .004, p = .015, and p = .005, respectively). Moreover, we observed a positive correlation between olive oil, fish consumption and LTL (r2 = .083, p = .010; r2 = .090, p = .006, respectively). Subjects who consumed more than 30 mL olive oil/day had longer LTL than subjects with lower consumption (p = .013). Furthermore, we observed higher glutathione peroxidase activity in subjects consuming less vitamin E (p = .031). Our findings support the importance of an adequate consumption of the antioxidant vitamin E, and the value of the diet as a modulating tool of the senescence process.
Journal of Nutritional Biochemistry | 2018
Irene Roncero-Ramos; Rosa Jimenez-Lucena; Juan F. Alcala-Diaz; Cristina Vals-Delgado; Antonio P. Arenas-Larriva; Oriol A. Rangel-Zuñiga; Ana Leon-Acuña; María M. Malagón; Javier Delgado-Lista; Pablo Perez-Martinez; Jose M. Ordovas; Antonio Camargo; Jose Lopez-Miranda
Abstract Alpha- and beta-cells dysfunction is implicated in the development of Type 2 diabetes mellitus (T2DM). We aimed to evaluate whether alpha- and beta-cell dysfunction may precede prediabetes (PreDM) and T2DM development. Furthermore, we explored the role of two healthy diets (Mediterranean and low-fat diets) modulating these processes. We included 462 patients from the CORDIOPREV study without T2DM at baseline, of which 272 were PreDM. During follow-up, 107 patients developed T2DM (T2DM-incident group), 30 developed PreDM (PreDM-incident group), 86 regressed to normoglycemia (PreDM-regression group) and 29 patients remained without PreDM or T2DM criteria (control group), according to the American Diabetes Association diagnosis criteria. We measured glucose, insulin, glucagon and GLP-1 plasma levels in the OGTT performed at baseline and after 2 years of follow-up. Patients were randomized to consume two healthy diets, a Mediterranean (>35%) and a low-fat (
Experimental Gerontology | 2017
Javier Lopez-Moreno; Sonia Garcia-Carpintero; Francisco Gomez-Delgado; Rosa Jimenez-Lucena; Cristina Vals-Delgado; Juan F. Alcala-Diaz; Irene Roncero-Ramos; Oriol A. Rangel-Zuñiga; Elena M. Yubero-Serrano; María M. Malagón; Jose M. Ordovas; Pablo Perez-Martinez; Jose Lopez-Miranda; Antonio Camargo
Background: Aging is an important determinant of the rate of atherosclerosis development, mainly through low‐grade inflammation. Diet, and particularly its fat content, modulates the inflammatory response in fasting and postprandial states. Objective: We aimed to study the effects of dietary fat on endotoxemia in healthy older adults. Materials and methods: Twenty healthy older adults were randomized to three diets, lasting three‐weeks each, using a crossover design: 1. A Mediterranean diet enriched in MUFA with virgin olive oil. 2. An SFA‐rich diet. 3. A low‐fat high‐carbohydrate diet enriched in n‐3 PUFA (&agr;‐linolenic acid of plant origin) (CHO‐PUFA diet). At the end of each period, after a 12‐h fast, the subjects received a meal with a composition similar to the dietary period just completed. We determined the fasting and the postprandial plasma levels of lipopolysaccharide (LPS) and LPS‐binding protein (LBP). Results: In the fasting state, we observed lower LPS plasma levels after the consumption of the CHO‐PUFA diet (P = 0.046) in comparison with the consumption of the Med and SFA‐rich diets. In the postprandial measurements, we observed a statistically significant increase in plasma levels of LPS (P = 0.044) and a decrease in LBP (P = 0.003) after the intake of the CHO‐PUFA meal, whereas no postprandial changes were observed after the ingestion of the Med and SFA‐rich meals. Conclusion: Our results, together with those obtained in a previous study, support the concept that the consumption of the Med Diet, in contrast to a low‐fat PUFA diet, constitutes a more suitable dietary lifestyle for preventing the development of atherosclerosis in a population at risk, such as older adults. HighlightsAging‐associated inflammation is an important determinant of atherosclerosis development.Med Diet reduces postprandial inflammatory response more than a low‐fat PUFA diet.CHO‐PUFA diet reduced the LPS fasting plasma levels, but increased postprandial levels.Med Diet is more suitable than a low‐fat PUFA diet for preventing aging‐associated atherosclerosis.
Molecular Nutrition & Food Research | 2018
Irene Roncero-Ramos; Oriol A. Rangel-Zuñiga; Javier Lopez-Moreno; Juan F. Alcala-Diaz; Pablo Perez-Martinez; Rosa Jimenez-Lucena; Justo P. Castaño; Helen M. Roche; Javier Delgado-Lista; Jose M. Ordovas; Antonio Camargo; Jose Lopez-Miranda
Clinical Nutrition | 2018
Antonio Camargo; Rosa Jimenez-Lucena; Juan F. Alcala-Diaz; Oriol A. Rangel-Zuñiga; Sonia Garcia-Carpintero; Javier Lopez-Moreno; Ruth Blanco-Rojo; Javier Delgado-Lista; Pablo Perez-Martinez; Ben van Ommen; María M. Malagón; Jose M. Ordovas; Francisco Perez-Jimenez; Jose Lopez-Miranda
Atherosclerosis | 2018
I. Roncero-Ramos; Javier Lopez-Moreno; Rosa Jimenez-Lucena; Francisco Gomez-Delgado; C. Vals-Delgado; Javier Delgado-Lista; Antonio Camargo; Jose Lopez-Miranda